Daiichi says offer for Ranbaxy oversubscribed
September 25th, 2008 by 
admin Japan’s third-largest drugmaker Daiichi Sankyo Co said its unstoppered substance to acquire up to 20 proportionality of generic drugmaker Ranbaxy Laboratories Ltd was oversubscribed
Posted in Pharmaceuticals | 